![Jaime Bartushak](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: 659 931 $ in data 31/05/2026
Jaime Bartushak is the founder.
Mr. Bartushak was the Chief Financial Officer at Leonard-Meron Biosciences, Inc. since 2014.
Mr. Bartushak is the CFO, Chief Accounting & Business Officer at Citius Pharmaceuticals, Inc. since 2022.
Mr. Bartushak is the Chief Financial Officer & Treasurer at Citius Oncology, Inc. since 2024.
Education includes undergraduate and graduate degrees from New Jersey Institute of Technology.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
0,89% | 19/09/2025 | 825.000 ( 0,89% ) | 658 350 $ | 31/05/2026 |
| 13/02/2026 | 2.414 ( 0,01% ) | 1 581 $ | 31/05/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| CITIUS PHARMACEUTICALS, INC. | Direttore Finanziario/CFO | 27/11/2017 |
| Società | Posizione | Fine |
|---|---|---|
Leonard-Meron Biosciences, Inc.
 Leonard-Meron Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as pharmaceutical company that develops and commercializes critical care products | Fondatore | 01/11/2017 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 3 |
|---|---|
Citius Pharmaceuticals, Inc.
 Citius Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Operates as a pharmaceutical company | Health Technology |
New Jersey Institute of Technology
 New Jersey Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Leonard-Meron Biosciences, Inc.
Leonard-Meron Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as pharmaceutical company that develops and commercializes critical care products | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
